These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20116648)

  • 21. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.
    Rashidi A; Ghanbarian A; Azizi F
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):976-83. PubMed ID: 17702729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
    Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
    J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease epidemics--a gap in effectiveness: the distance between potential and actual treatment benefits.
    Zoccali C; Cambareri F
    J Nephrol; 2006; 19(2):131-4. PubMed ID: 16736409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
    Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
    Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?
    Schelling JR; Sedor JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2773-4. PubMed ID: 15504930
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
    Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
    Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we quantify insulin resistance in patients with renal disease?
    Shen Y; Peake PW; Kelly JJ
    Nephrology (Carlton); 2005 Dec; 10(6):599-605. PubMed ID: 16354245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome and cardiovascular disease.
    Vitarius JA
    Mt Sinai J Med; 2005 Jul; 72(4):257-62. PubMed ID: 16021320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The global burden of chronic kidney disease and the way forward.
    Alebiosu CO; Ayodele OE
    Ethn Dis; 2005; 15(3):418-23. PubMed ID: 16108301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of chronic kidney disease among the Zuni Indians: the Zuni Kidney Project.
    Scavini M; Stidley CA; Paine SS; Shah VO; Tentori F; Bobelu A; Welty TK; MacCluer JW; Zager PG
    Clin J Am Soc Nephrol; 2007 May; 2(3):509-16. PubMed ID: 17699458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating.
    Gobal F; Deshmukh A; Shah S; Mehta JL
    J Am Coll Cardiol; 2011 Jun; 57(23):2303-8. PubMed ID: 21636030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and chronic kidney disease.
    Ching-Ha Kwan B; Beddhu S
    Minerva Urol Nefrol; 2006 Mar; 58(1):1-12. PubMed ID: 16760879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of metabolic syndrome on chronic kidney disease].
    Calò LA
    Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney damage in metabolic syndrome: nip it in the bud.
    Ritz E
    Am J Kidney Dis; 2009 May; 53(5):726-9. PubMed ID: 19393470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.